SOBI•prnewswire•
Sobi's 2025 annual revenue and adjusted EBITA margin exceed previous outlook
Summary
STOCKHOLM, Jan. 15, 2026 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO: SOBI) announces today that revenue and adjusted EBITA margin for the full year 2025 were higher than previous outlook. Full-year revenue was approximately SEK 28.2 B, representing approximately 15...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on January 15, 2026 by prnewswire